Relevant to: All Prescription Drug Plans, Medicare Advantage-Prescription Drug Plans, and Section 1876 Cost Plans
The CMS Innovation Center has announced that the Medicare Advantage (MA) Value-Based Insurance Design (VBID) Model will continue until Calendar Years 2025-2030. The model aims to improve care coordination for patients with serious illness, address health-related social needs, and advance health equity. The CMS Innovation Center will provide additional information about updates to the model soon. Interested parties can contact the model team at VBID@cms.hhs.gov.